2026-11-092026-11-09https://scholars.csmu.edu.tw/handle/123456789/38751This project has the main goal to fully improve the key environment to promote new drug marketing, focus on ethics, government regulations, GCP and GLP especially. From the very initial of trial design, protocol writing to trial submitting & reviewing, all can fit in with the regulations. In the future, we can actively integrate doctors in our hospital, pharmaceutical companies, bio-technologic companies, CROs and DOH regulation units, taking co-operation based on the SMO model to create more chances. Finally, drive Taiwan to be the international “Asia-Pacific Clinical Trial Center”.本計畫以全面提升藥物上市臨床試驗之關鍵環境為主要目標,著重符合人體試驗倫理、法規管理、藥品(暨醫療器材草案)優良臨床試驗規範,優良實驗室規範等,以執行優質臨床試驗為目標,並全方位提昇新藥臨床試驗之品質,包括從最初臨床試驗設計、計畫書撰寫、案件的申請與送審等,均能符合法規要求。我們為維護受試者安全與試驗品質,更需建立安全良好的臨床試驗場所,以保障執行臨床試驗各項數值與資料的正確性與可信度。 未來本院「西藥醫材暨新醫療技術臨床試驗中心」在現有良好基礎下,更能積極發揮全方位臨床試驗管理機構的角色功能,主動整合與調節本院內優秀臨床醫師擔任計劃主持人,並且積極接洽國內外藥廠、生物製藥/生技公司、委辦服務機構及衛生署法規單位等機構。臨床試驗新藥研發clinical trialnew drug development全面提升藥物上市臨床試驗之關鍵環境Project